InfuSystem Holdings (INFU) Enterprise Value Growth (5y) (2015 - 2026)
InfuSystem Holdings (INFU) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn |
| 10 | InfuSystem Holdings | 189.58 Mn | 187.47 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.32% |
| Dec 31, 2025 | 19.88% |
| Sep 30, 2025 | 13.21% |
| Jun 30, 2025 | -8.36% |
| Mar 31, 2025 | -37.63% |
| Dec 31, 2024 | 27.59% |
| Sep 30, 2024 | 34.52% |
| Jun 30, 2024 | 38.81% |
| Mar 31, 2024 | 15.43% |
| Dec 31, 2023 | 44.32% |
| Sep 30, 2023 | 47.09% |
| Jun 30, 2023 | 43.66% |
| Mar 31, 2023 | 30.06% |
| Dec 31, 2022 | 45.62% |
| Sep 30, 2022 | 14.68% |
| Jun 30, 2022 | -32.55% |
| Mar 31, 2022 | -15.86% |
| Dec 31, 2021 | 44.07% |
| Sep 30, 2021 | 31.22% |
| Jun 30, 2021 | 27.25% |